` INCR (InterCure Ltd) vs Tel Aviv 355 Comparison - Alpha Spread

INCR
vs
Tel Aviv 355

Over the past 12 months, INCR has underperformed Tel Aviv 355, delivering a return of -30% compared to the Tel Aviv 355's 44% growth.

Stocks Performance
INCR vs Tel Aviv 355

Loading
INCR
Tel Aviv 355
Add Stock
www.alphaspread.com

Performance Gap
INCR vs Tel Aviv 355

Loading
INCR
Tel Aviv 355
Difference
www.alphaspread.com

Performance By Year
INCR vs Tel Aviv 355

Loading
INCR
Tel Aviv 355
Add Stock

Competitors Performance
InterCure Ltd vs Peers

Tel Aviv 355
INCR
LLY
JNJ
NOVO B
ROG
Add Stock

InterCure Ltd
Glance View

Market Cap
255.1m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 499.08 ILS
Undervaluation 65%
Intrinsic Value
Price
I
Back to Top